Quantification of the eGFP to mCherry ratio following Her2 downregulation revealed progressive enrichment for eGFP-expressing Paqr8-OE cells across multiple stages of tumor progression, eventually resulting in recurrent tumors with > 90% Paqr8-OE cells (Fig. 3B). The gene discussed is PAQR8; the disease is neoplasm.